Literature DB >> 3352272

Establishment and characterization of a human urinary bladder carcinoma cell line (TSGH-8301).

M Y Yeh1, D S Yü, S C Chen, M S Lin, S Y Chang, C P Ma, S H Han.   

Abstract

A cell line derived from a well-differentiated human transitional cell carcinoma of the urinary bladder, designated TSGH-8301, was established in vitro. The cultured epithelioid cells exhibited monolayer growth and loss of contact inhibition. The tumorigenicity of TSGH-8301 had been shown by growth in soft agar and tumor induction in athymic nude mice. A reverse ratio of lactate dehydrogenase (LHD) isoenzyme in the cell line and nude mouse-grown tumors was seen predominantly with LDH-V. Chromosomal analysis revealed a heterodiploid stem line with a modal number of 50. Sera of urinary bladder cancer patients reacted with membrane antigens of the TSGH-8301 cells, suggesting the existence of tumor-associated antigens in the cells. In vitro chemosensitivity tests of these cells may provide data valuable in the selection of proper anticancer drugs for the TSGH-8301 donor patient.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3352272     DOI: 10.1002/jso.2930370310

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  12 in total

1.  Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model.

Authors:  Cheng-Huang Shen; Jia-Jen Shee; Jin-Yi Wu; Yi-Wen Lin; Jiann-Der Wu; Yi-Wen Liu
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.

Authors:  Chi-Chen Lu; Mei-Yi Lin; Syue-Yi Chen; Cheng-Huang Shen; Lih-Geeng Chen; Hsiao-Yen Hsieh; Michael W Y Chan; Cheng-Da Hsu
Journal:  BMC Complement Altern Med       Date:  2013-02-23       Impact factor: 3.659

3.  Aqueous Extract of Shi-Liu-Wei-Liu-Qi-Yin Induces G2/M Phase Arrest and Apoptosis in Human Bladder Carcinoma Cells via Fas and Mitochondrial Pathway.

Authors:  Ting-Tsz Ou; Chau-Jong Wang; Guang-Uei Hung; Cheng-Hsun Wu; Huei-Jane Lee
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-03       Impact factor: 2.629

4.  H-Ras oncogene counteracts the growth-inhibitory effect of genistein in T24 bladder carcinoma cells.

Authors:  C Li; R-H Teng; Y-C Tsai; H-S Ke; J-Y Huang; C-C Chen; Y-L Kao; C-C Kuo; W R Bell; B Shieh
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

5.  Gab1 is essential for membrane translocation, activity and integrity of mTORCs after EGF stimulation in urothelial cell carcinoma.

Authors:  Chi-Hao Chang; Po-Chao Chan; Jian-Ri Li; Chun-Jung Chen; Jeng-Jer Shieh; Yun-Ching Fu; Hong-Chen Chen; Ming-Ju Wu
Journal:  Oncotarget       Date:  2015-01-30

6.  The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma.

Authors:  Chien-Feng Li; Wen-Jeng Wu; Wen-Ren Wu; Yu-Jing Liao; Lih-Ren Chen; Chun-Nung Huang; Ching-Chia Li; Wei-Ming Li; Hsuan-Ying Huang; Yi-Ling Chen; Shih-Shin Liang; Nan-Haw Chow; Yow-Ling Shiue
Journal:  Oncotarget       Date:  2015-04-20

7.  Cantharidin alters the expression of genes associated with the NKG2D-associated immune response in TSGH-8301 human bladder carcinoma cells.

Authors:  Jehn-Hwa Kuo; An-Cheng Huang; Jen-Jyh Lin; Kuang-Chi Lai; Rick Sai-Chuen Wu; Jiun-Long Yang; Bin-Chuan Ji; Mei-Due Yang; Yung-Lin Chu; Jing-Gung Chung
Journal:  Oncol Lett       Date:  2017-05-12       Impact factor: 2.967

8.  Promoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma.

Authors:  Meei-Maan Wu; Ching-Fei Li; Li-Fang Lin; Alexander Sheng-Shin Wang; Yeong-Shiau Pu; Hsiu-Hua Wang; Ai-Chung Mar; Chien-Jen Chen; Te-Chang Lee
Journal:  Oncotarget       Date:  2017-04-04

9.  Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1-5.

Authors:  J-L Hsieh; C-L Wu; M-D Lai; C-H Lee; C-S Tsai; A-L Shiau
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

10.  Clarification of the molecular pathway of Taiwan local pomegranate fruit juice underlying the inhibition of urinary bladder urothelial carcinoma cell by proteomics strategy.

Authors:  Ting-Feng Wu; Li-Ting Hsu; Bo-Xian Tsang; Li-Chien Huang; Wan-Yin Shih; Li-Yi Chen
Journal:  BMC Complement Altern Med       Date:  2016-03-09       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.